Literature DB >> 17615085

Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective.

I C Ditah1, M Reacher, C Palmer, J M Watson, J Innes, M E Kruijshaar, H N Luma, I Abubakar.   

Abstract

BACKGROUND: In 1998, the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) published recommendations standardising the evaluation of tuberculosis treatment outcome in Europe. These guidelines fail to account for clinically appropriate alterations in the management of patients.
OBJECTIVES: To evaluate tuberculosis treatment outcome in England, Wales and Northern Ireland by redefining the outcome criteria and investigate factors associated with unsuccessful treatment outcome 12 months after notification.
METHODS: This was a prospective analysis of a cohort of patients diagnosed in England, Wales and Northern Ireland and reported to the Enhanced Tuberculosis Surveillance system in 2001 and 2002. Proportions of success and failure were calculated based on a new set of criteria following discussion with clinicians treating tuberculosis cases. Logistic regression was used to study risk factors for unsuccessful treatment outcome.
RESULTS: 13 048 cases were notified in the study period. Of the 2676 that were identified as new sputum smear positive pulmonary cases, 2209 (82.5%) had treatment outcome data reported. Using the WHO/IUATLD criteria, 76.8% were classified as successful. In contrast, applying the new criteria, the success rate was 87.5%. This rate exceeds the 85% success target set by the WHO. Risk factors for unsuccessful treatment outcome included male sex (OR 1.27; 95% CI 1.08 to 1.49), being elderly (p trend < 0.001), having pulmonary tuberculosis (OR 1.28; 95% CI 1.08 to 1.53) and having resistance to any antituberculosis drug (OR 1.90; 95% CI 1.44 to 2.52).
CONCLUSION: The proportion of tuberculosis cases with a successful treatment outcome exceeded the target of 85% success rate based on the modified outcome categories. Although the tuberculosis treatment outcome criteria set by WHO/IUATLD appear to be clear, they mix measures of process and outcome. Further refinement may be necessary in low incidence high income countries, especially those with a high mortality among the elderly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615085     DOI: 10.1136/thx.2006.073916

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  31 in total

1.  Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand.

Authors:  Sakarn Charoensakulchai; Manasak Limsakul; Inkharat Saengungsumalee; Sirawich Usawachoke; Aticha Udomdech; Anintita Pongsaboripat; Wisit Kaewput; Boonsub Sakboonyarat; Ram Rangsin; Picha Suwannahitatorn; Mathirut Mungthin; Phunlerd Piyaraj
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

2.  Profile and treatment outcomes of patients with tuberculosis in Northeastern Ethiopia: a cross sectional study.

Authors:  Daniel Mekonnen; Awoke Derbie; Hailu Mekonnen; Yohannes Zenebe
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

3.  Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study.

Authors:  Tuula Vasankari; Pekka Holmström; Jukka Ollgren; Kari Liippo; Petri Ruutu
Journal:  BMC Public Health       Date:  2010-07-06       Impact factor: 3.295

4.  Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Authors:  H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

5.  Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.

Authors:  Christof J Majoor; Cecile Magis-Escurra; Jakko van Ingen; Martin J Boeree; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

6.  Two-thirds of smear-positive tuberculosis cases in the community were undiagnosed in Northwest Ethiopia: population based cross-sectional study.

Authors:  Takele Tadesse; Meaza Demissie; Yemane Berhane; Yigzaw Kebede; Markos Abebe
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

7.  Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.

Authors:  S N Oshi; I Alobu; K N Ukwaja; D C Oshi
Journal:  Epidemiol Infect       Date:  2014-10-30       Impact factor: 4.434

8.  Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland.

Authors:  Omar Kherad; François R Herrmann; Jean-Pierre Zellweger; Thierry Rochat; Jean-Paul Janssens
Journal:  BMC Infect Dis       Date:  2009-12-31       Impact factor: 3.090

Review 9.  Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

Authors:  Rob van Hest; Csaba Ködmön; Suzanne Verver; Connie G M Erkens; Masja Straetemans; Davide Manissero; Gerard de Vries
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

10.  Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data.

Authors:  E R C Millett; D Noel; P Mangtani; I Abubakar; M E Kruijshaar
Journal:  Epidemiol Infect       Date:  2012-07-30       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.